RITUXIMAB VS. COMBINATION OF RITUXIMAB AND CYCLOPHOSPHAMIDE INDUCTION THERAPY FOR ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE STUDY

被引：0
|
作者：
Von Allwoerden, K. [1 ]
Klapa, S. [1 ]
Werth, S. C. [2 ]
Mueller, A. [1 ]
Riemekasten, G. [1 ]
Nitschke, M. [2 ]
Thaci, D. [3 ]
Lamprecht, P. [1 ]
机构：
[1] Univ Lubeck, Rheumatol, Lubeck, Germany
[2] Univ Lubeck, Nephrol, Lubeck, Germany
[3] Univ Lubeck, Entzundungsmed, Lubeck, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Real-world evidence; Quality of care; Vasculitis;
D O I：
10.1136/annrheumdis-2023-eular.3867
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1161
引用
收藏
页码：912 / 913
页数：2
相关论文
共 50 条
  • [1] Rituximab vs cyclophosphamide for cancer risk in ANCA-associated vasculitis
    Mahajan, Arjun
    Viola, Martin
    Ellen, Jacob
    Piette, Evan W.
    LaChance, Avery H.
    Sparks, Jeffrey A.
    RHEUMATOLOGY, 2025,
  • [2] Rituximab or Cyclophosphamide in ANCA-Associated Renal Vasculitis
    Hebert, Lee A.
    Ardoin, Stacy
    Shim, Rosemarie L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (21): : 2072 - 2073
  • [3] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
    Dejaco, C.
    Duftner, C.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2010, 17 (04): : 168 - 168
  • [4] Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
    Cortazar, Frank B.
    Muhsin, Saif A.
    Pendergraft, William F., III
    Wallace, Zachary S.
    Dunbar, Colleen
    Laliberte, Karen
    Niles, John L.
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (02): : 394 - 402
  • [5] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
    Stone, John H.
    Merkel, Peter A.
    Spiera, Robert
    Seo, Philip
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Clair, E. William St.
    Turkiewicz, Anthony
    Tchao, Nadia K.
    Webber, Lisa
    Ding, Linna
    Sejismundo, Lourdes P.
    Mieras, Kathleen
    Weitzenkamp, David
    Ikle, David
    Seyfert-Margolis, Vicki
    Mueller, Mark
    Brunetta, Paul
    Allen, Nancy B.
    Fervenza, Fernando C.
    Geetha, Duvuru
    Keogh, Karina A.
    Kissin, Eugene Y.
    Monach, Paul A.
    Peikert, Tobias
    Stegeman, Coen
    Ytterberg, Steven R.
    Specks, Ulrich
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 221 - 232
  • [6] Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
    Jones, Rachel
    Tervaert, Jan Willem Cohen
    Hauser, Thomas
    Luqmani, Raashid
    Peh, Chen A. U.
    Savage, Caroline
    Segelmark, Marten
    Tesar, Vladimir
    Van Paassen, Pieter
    Walsh, Michael
    Walsh, Dorothy
    Westman, Kerstin
    Jayne, David
    APMIS, 2009, 117 : 78 - 78
  • [7] Rituximab maintenance therapy in ANCA-associated vasculitis
    Lorenz, Judith
    AKTUELLE RHEUMATOLOGIE, 2024, 49 (05) : 281 - 281
  • [8] RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS
    Mukhtyar, Chetan
    RHEUMATOLOGY, 2013, 52 : 5 - 6
  • [9] Rituximab in ANCA-Associated Vasculitis
    Hassan, Romina I.
    Gaffo, Angelo L.
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (02)
  • [10] Rituximab in ANCA-Associated Vasculitis
    Romina I. Hassan
    Angelo L. Gaffo
    Current Rheumatology Reports, 2017, 19
12345